利用密码子优化DNA定量分析家蚕蛹中产生的禽H7流感病毒血凝素蛋白产量:一种可能的口服疫苗
本研究在家蚕蛹中利用密码子优化的单一HA基因,定量比较三种H7流感病毒样颗粒血凝素产量,重组杆状病毒(Korea H7-BmNPV)每蛹产0.40百万HA单位(对应1832μg蛋白),幼虫产量约0.31百万HA单位,三种HA蛋白间无显著差异;并建立超声回收体系,比较mRNA合成作为指标,电镜观察VLP,纯化VLP与抗体反应,口服免疫鸡和小鼠产生HI抗体,为口服疫苗开发提供见解。
要点
- 重组杆状病毒Korea H7-BmNPV每蛹产0.40百万HA单位,对应1832μg蛋白。
- 幼虫产量约0.31百万HA单位,三种HA蛋白间无显著差异。
- 口服免疫H5和H7 VLP可在鸡和小鼠中产生HI抗体。
核心结论
- 这些发现为未来口服疫苗开发提供了重要见解。
研究设计与样本
- 本研究利用密码子优化的单一HA基因在家蚕蛹中定量比较三种H7流感病毒样颗粒血凝素的产量。
主要发现
- 重组杆状病毒(Korea H7-BmNPV)每蛹产0.40百万HA单位,对应1832μg蛋白。
- 幼虫中HA产量估计约为每幼虫0.31百万HA单位,三种HA蛋白间无显著差异。
- 基于BmN细胞中mRNA合成量比较三种不同H7和两种H5重组杆状病毒的HA蛋白产量,提示mRNA合成可能也是HA生产的有用指标。
- 含有密码子优化HA DNA的A/tufted duck/Fukushima/16/2011(H5N1)重组体产生超过一百万HA单位,而包含野生H5N1株的另一重组体未能显示HA活性。
- 电镜显示重和轻组分中存在大VLP和小HA颗粒;纯化VLPs与抗H7抗体及VLP H7抗原免疫后制备的抗体反应;H5和H7 VLPs口服免疫鸡和小鼠可产生HI抗体。
关键数值与推荐
- Korea H7-BmNPV每蛹产0.40百万HA单位,对应1832μg蛋白。
- 幼虫HA产量约0.31百万HA单位/幼虫,三种HA蛋白间无显著差异。
- 密码子优化H5N1 HA重组体产生超过一百万HA单位,野生H5N1重组体无HA活性。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In this study, we aimed to quantitatively compare the increased production of three H7 influenza virus-like particle (VLP) haemagglutinin (HA) with the use of a codon-optimized single HA gene in silkworm pupae. Recombinant baculovirus (Korea H7-BmNPV) could produce 0.40 million HA units per pupa, corresponding to 1832μg protein. The yield of the HA produced in larva was estimated to be approximately 0.31 million HA units per larva, and there were no significant differences between the three HA proteins. We could establish efficient recovery system of HA production in larvae and pupae with the use of three cycles sonication methods. Next, we compared yields of HA proteins from three different H7 and two H5 recombinant baculoviruses based on the amount of mRNA synthesized in BmN cells, suggesting that mRNA synthesis may be also a useful indicator for the production of HA. Based on HA titres from four recombinants, the yield of HA had a great influence on the codon-optimized effect and the characteristics of the viral HA gene. The recombinant containing codon optimized HA DNA of A/tufted duck/Fukushima/16/2011 (H5N1) did produce more than one million HA units, although another recombinant including of the wild H5N1 strain failed to show HA activity. Electron microscopy revealed the presence of large VLP and small HA particle in the heavy and light fractions. The purified VLPs reacted with the authentic anti-H7 antibodies and the antibodies prepared after immunization with the VLP H7 antigen. Also H5 and H7VLPs could produce HI antibody in chickens and mice with oral immunization. The antibodies elicited with oral immunization were confirmed in fluorescent antibody analysis and western blotting in Korea H5-BmNPV and H7HA-BmNPV recombinant infected BmN cells. Taken together, these findings provided important insights into future oral vaccine development.
引用
- Nerome K, Matsuda S, Maegawa K, et al. Quantitative analysis of the yield of avian H7 influenza virus haemagglutinin protein produced in silkworm pupae with the use of the codon-optimized DNA: A possible oral vaccine. Vaccine. 2017. PMID: 28065477. doi:10.1016/j.vaccine.2016.12.058
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。